Hot Topics in FDA Regulation: GLP-1s, LDTs, AI and More

In this episode of Holland & Knight's "The Eyes on Washington" podcast series, attorneys Rachel Gartner, Sara Klock, John Vaughan and Michael Werner discuss the evolving landscape of U.S. Food and Drug Administration (FDA) regulation throughout the early months of the Trump Administration. Key topics include the significant organizational changes at the FDA, ongoing legal battles over compounded GLP-1 drugs and their market access, regulatory uncertainties surrounding laboratory-developed tests (LDTs) and anticipated reforms in food ingredient safety and cosmetic product oversight. The conversation also explores the administration's shifting approach to the regulation of artificial intelligence (AI) in healthcare, predicting a lighter federal touch with increased state-level  ...